oa SA Pharmaceutical Journal - National Guidelines at a glance : GORD : review
|Article Title||National Guidelines at a glance : GORD : review|
|© Publisher:||Medpharm Publications|
|Journal||SA Pharmaceutical Journal|
|Publication Date||Oct 2009|
|Pages||32 - 36|
Gastro-Oesophageal Reflux Disease (GORD), with its main symptoms of heartburn and regurgitation, is one of the most common conditions affecting the oesophagus, with an estimated 24% of the population experiencing heartburn daily or more often and 43% once or twice a week. Chronic heartburn is typically experienced for periods ranging from less than a year (15%) to more than 10 years (29%). GORD is one of the most prevalent disorders seen in both primary and secondary care settings, thus has a considerable economic impact in terms of medication costs. Although GORD is most common in adults over age 40, anyone can get GORD, even infants.
Article metrics loading...